Divi's Laboratories Ltd. (DIVI)

Currency in INR
6,151.50
+123.50(+2.05%)
Closed·
DIVI Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
DIVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6,088.006,188.00
52 wk Range
4,828.957,071.50
Key Statistics
Bid/Ask
6,151.50 / 6,154.00
Prev. Close
6,028
Open
6,088
Day's Range
6,088-6,188
52 wk Range
4,828.95-7,071.5
Volume
681.52K
Average Volume (3m)
396.54K
1-Year Change
23%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DIVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6,384.14
Upside
+3.78%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Divi's Laboratories Ltd. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Divi's Laboratories Ltd. Company Profile

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Employees
10542
Market
India

Compare DIVI to Peers and Sector

Metrics to compare
DIVI
Peers
Sector
Relationship
P/E Ratio
70.7x36.7x−0.6x
PEG Ratio
1.880.330.00
Price/Book
10.9x3.0x2.6x
Price / LTM Sales
16.9x3.2x3.3x
Upside (Analyst Target)
4.0%8.6%40.0%
Fair Value Upside
Unlock−4.5%4.7%Unlock

Analyst Ratings

10 Buy
7 Hold
11 Sell
Ratings:
28 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6,384.14
(+3.78% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 86.82%
Dividend Yield
0.49%
Industry Median 0.75%
Annualised payout
30.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
20.50 / 22.02
Revenue / Forecast
24.10B / 24.51B
EPS Revisions
Last 90 days

DIVI Income Statement

People Also Watch

5,924.50
EICH
-0.85%
1,505.00
TEML
-1.07%
1,592.80
CIPL
0.00%
1,986.60
KTKM
-1.55%
3,403.00
MAHM
+0.83%

FAQ

What Stock Exchange Does Divi's Labs Trade On?

Divi's Labs is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Divi's Labs?

The stock symbol for Divi's Labs is "DIVI."

What Is the Divi's Labs Market Cap?

As of today, Divi's Labs market cap is 1.63T.

What Is Divi's Labs's Earnings Per Share (TTM)?

The Divi's Labs EPS (TTM) is 86.82.

When Is the Next Divi's Labs Earnings Date?

Divi's Labs will release its next earnings report on 09 Nov 2025.

From a Technical Analysis Perspective, Is DIVI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Divi's Labs Stock Split?

Divi's Labs has split 3 times.

How Many Employees Does Divi's Labs Have?

Divi's Labs has 10542 employees.

What is the current trading status of Divi's Labs (DIVI)?

As of 22 Aug 2025, Divi's Labs (DIVI) is trading at a price of 6,151.50, with a previous close of 6,028.00. The stock has fluctuated within a day range of 6,088.00 to 6,188.00, while its 52-week range spans from 4,828.95 to 7,071.50.

What Is Divi's Labs (DIVI) Price Target According to Analysts?

The average 12-month price target for Divi's Labs is INR6384.13793, with a high estimate of INR7750 and a low estimate of INR4250. 10 analysts recommend buying the stock, while 11 suggest selling, leading to an overall rating of Neutral. The stock has an +3.78% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.